Implantable Neurostimulators Market (By Type - Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Gastric Electric Stimulators. By Application - Pain Management, Parkinson’s disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis. By Geography – North America, South America, Middle East and Africa, Europe, Asia Pacific.) - Industry analysis, size, share, growth, trends and forecast, 2021 – 2031.

The Global Implantable Neurostimulators Market was $4.92 Bn in 2020, and it is expected to reach $13.4 Bn by 2031. It is eventually growing at a commendable high compound annual growth rate CAGR of 9.3% between 2021-2031. But due to the current COVID-19 pandemic, there might be a slight difference in the growth rate in the present year. Increased cases of chronic disorders like movement disorders, epilepsy, chronic pain, depression, Parkinson’s disease, and also the advancements in the minimally invasive neurosurgical procedures will help to accelerate the growth of this market during the forecasted period.

Global Implantable Neurostimulators Market Is Estimated To Witness Remarkable Growth

Source: SAI Research

The Global Implantable Neurostimulators Market has been segmented into type and application. On the basis of type Global Implantable Neurostimulators Market has been segmented into Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, and Gastric Electric Stimulators. On the basis of application it has been segmented into Pain Management, Parkinson’s disease, Urinary, and Fecal Incontinence, Epilepsy, Gastroparesis.

By Region, North America Is Holding the Major Market Share

The Global Implantable Neurostimulators Market has been geographically segmented into North America, Asia Pacific, Latin America, Middle East, and Africa region. in addition to this, North America Global Implantable Neurostimulators Market is holding the largest market share at present and is estimated to witness high compound annual growth during the upcoming forecasted period. Developments and introduction of new and innovative neurostimulators, approval by regulatory authorities for new techniques in the devices and also the presence of well-established healthcare infrastructure has led this region dominates the market. Besides this Asia Pacific is also going to witness remarkable growth during the upcoming forecasted period.

Major Players in Global Implantable Neurostimulators Market

Some of the major players in the Global Implantable Neurostimulators Market include Abbott (St. Jude Medical), Medtronic, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Synapse Biomedical Inc., Nevro Corp., LivaNova PLC, NeuroPace, Inc., Beijing Pins, Synapse Biomedical.

The Global Implantable Neurostimulators Market Has Been Segmented Into:

 Global Implantable Neurostimulators Market, By Type

• Deep Brain Stimulators
• Spinal Cord Stimulators
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators
• Gastric Electric Stimulators

Global Implantable Neurostimulators Market, By Application

• Pain Management
• Parkinson’s Disease
• Urinary and Fecal Incontinence
• Epilepsy
• Gastroparesis

Global Implantable Neurostimulators Market, By Region

• North America
• USA
• Canada
• Mexico
• Rest of North America
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• India
• China
• Japan
• South Korea
• Rest of Asia Pacific
• Latin America, Middle East & Africa
• Brazil
• South Africa
• UAE
• Rest of LAMEA